MoonLake Immunotherapeutics (MLTXN.MX) Q1 2025 Earnings

26FebConfirmed
Q4 2024
Q1 2025
-14.7
-12.67
-10.64
-8.62

Details

Expected EPS
-12.66177439384
Actual EPS
-14.6976192
Surprise EPS
-2.04
Surprise Percent
+16.08%

Description

MoonLake Immunotherapeutics (MLTXN.MX) has reported earnings of -14.6976192 per share for Q1 2025.

0 Comments

Share your thoughts